The Cannabist Company Holdings Inc. (CBSTF)
CBSTF Stock Price Chart
Explore The Cannabist Company Holdings Inc. interactive price chart. Choose custom timeframes to analyze CBSTF price movements and trends.
CBSTF Company Profile
Discover essential business fundamentals and corporate details for The Cannabist Company Holdings Inc. (CBSTF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
6 May 2019
Employees
1.68K
Website
https://www.cannabistcompany.comCEO
David J. Hart
Description
The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.
CBSTF Financial Timeline
Browse a chronological timeline of The Cannabist Company Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 11 Mar 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.03, while revenue estimate is $86.50M.
Earnings released on 7 Aug 2025
EPS came in at -$0.16 falling short of the estimated -$0.03 by -451.72%, while revenue for the quarter reached $86.35M , beating expectations by +10.14%.
Earnings released on 7 May 2025
EPS came in at -$0.07 falling short of the estimated -$0.04 by -75.00%, while revenue for the quarter reached $87.44M , missing expectations by -1.97%.
Earnings released on 11 Mar 2025
EPS came in at -$0.34 falling short of the estimated -$0.04 by -750.00%, while revenue for the quarter reached $96.14M , beating expectations by +7.78%.
Earnings released on 7 Nov 2024
EPS came in at -$0.00 falling short of the estimated -$0.00 by -99.49%, while revenue for the quarter reached $114.78M , beating expectations by +5.03%.
Earnings released on 8 Aug 2024
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $125.16M , missing expectations by -1.67%.
Earnings released on 9 May 2024
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%, while revenue for the quarter reached $122.06M , missing expectations by -1.76%.
Earnings released on 13 Mar 2024
EPS came in at -$0.18 falling short of the estimated -$0.06 by -200.00%, while revenue for the quarter reached $131.91M , beating expectations by +3.36%.
Earnings released on 14 Nov 2023
EPS came in at -$0.09 falling short of the estimated -$0.05 by -80.00%, while revenue for the quarter reached $127.54M , missing expectations by -2.83%.
Earnings released on 30 Jun 2023
EPS came in at -$0.07 falling short of the estimated -$0.06 by -17.32%, while revenue for the quarter reached $130.95M , beating expectations by +4.92%.
Earnings released on 31 Mar 2023
EPS came in at -$0.09 falling short of the estimated -$0.08 by -15.81%, while revenue for the quarter reached $124.54M , beating expectations by +1.14%.
Earnings released on 31 Dec 2022
EPS came in at -$0.75 falling short of the estimated -$0.08 by -784.75%, while revenue for the quarter reached $126.38M , missing expectations by -5.74%.
Earnings released on 29 Sept 2022
EPS came in at -$0.08 falling short of the estimated -$0.08 by -4.15%, while revenue for the quarter reached $125.28M , missing expectations by -6.56%.
Earnings released on 29 Jun 2022
EPS came in at -$0.14 falling short of the estimated -$0.06 by -115.20%, while revenue for the quarter reached $128.47M , missing expectations by -8.93%.
Earnings released on 30 Mar 2022
EPS came in at -$0.07 falling short of the estimated -$0.05 by -55.75%, while revenue for the quarter reached $124.60M , missing expectations by -9.55%.
Earnings released on 30 Dec 2021
EPS came in at -$0.14 , while revenue for the quarter reached $138.81M .
Earnings released on 29 Sept 2021
EPS came in at -$0.11 falling short of the estimated -$0.05 by -113.45%, while revenue for the quarter reached $131.42M , missing expectations by -4.98%.
CBSTF Stock Performance
Access detailed CBSTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.